342 related articles for article (PubMed ID: 23933312)
41. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
42. Involvement of the ventral tegmental area in locomotion elicited from the nucleus accumbens or ventral pallidum.
Johnson K; Churchill L; Klitenick MA; Hooks MS; Kalivas PW
J Pharmacol Exp Ther; 1996 May; 277(2):1122-31. PubMed ID: 8627524
[TBL] [Abstract][Full Text] [Related]
43. Nucleus accumbens μ-opioid receptors mediate social reward.
Trezza V; Damsteegt R; Achterberg EJ; Vanderschuren LJ
J Neurosci; 2011 Apr; 31(17):6362-70. PubMed ID: 21525276
[TBL] [Abstract][Full Text] [Related]
44. DAMGO suppresses both excitatory and inhibitory synaptic transmission in supraoptic neurones of mouse hypothalamic slice preparations.
Honda E; Ono K; Inenaga K
J Neuroendocrinol; 2004 Mar; 16(3):198-207. PubMed ID: 15049850
[TBL] [Abstract][Full Text] [Related]
45. The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals.
Fusa K; Takahashi I; Watanabe S; Aono Y; Ikeda H; Saigusa T; Nagase H; Suzuki T; Koshikawa N; Cools AR
Neuroscience; 2005; 130(3):745-55. PubMed ID: 15590157
[TBL] [Abstract][Full Text] [Related]
46. Presynaptic actions of opioid receptor agonists in ventromedial hypothalamic neurons in estrogen- and oil-treated female mice.
Devidze N; Zhang Q; Zhou J; Lee AW; Pataky S; Kow LM; Pfaff DW
Neuroscience; 2008 Apr; 152(4):942-9. PubMed ID: 18343595
[TBL] [Abstract][Full Text] [Related]
47. Mu-opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1.
Connor M; Schuller A; Pintar JE; Christie MJ
Br J Pharmacol; 1999 Apr; 126(7):1553-8. PubMed ID: 10323586
[TBL] [Abstract][Full Text] [Related]
48. Intra-amygdalar injection of DAMGO: effects on c-Fos levels in brain sites associated with feeding behavior.
Levine AS; Olszewski PK; Mullett MA; Pomonis JD; Grace MK; Kotz CM; Billington CJ
Brain Res; 2004 Jul; 1015(1-2):9-14. PubMed ID: 15223361
[TBL] [Abstract][Full Text] [Related]
49. Opioid receptor antagonists discriminate between presynaptic mu and delta receptors and the adenylate cyclase-coupled opioid receptor complex in the brain.
Schoffelmeer AN; De Vries TJ; Hogenboom F; Hruby VJ; Portoghese PS; Mulder AH
J Pharmacol Exp Ther; 1992 Oct; 263(1):20-4. PubMed ID: 1328606
[TBL] [Abstract][Full Text] [Related]
50. Deltorphin II enhances extracellular levels of dopamine in the nucleus accumbens via opioid receptor-independent mechanisms.
Murakawa K; Hirose N; Takada K; Suzuki T; Nagase H; Cools AR; Koshikawa N
Eur J Pharmacol; 2004 Apr; 491(1):31-6. PubMed ID: 15102530
[TBL] [Abstract][Full Text] [Related]
51. Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by mu opioid receptors in the substantia nigra and ventral tegmental area.
Bontempi B; Sharp FR
J Neurosci; 1997 Nov; 17(21):8596-612. PubMed ID: 9334431
[TBL] [Abstract][Full Text] [Related]
52. Mu and delta opioid receptor regulation of pro-opiomelanocortin peptide secretion from the rat neurointermediate pituitary in vitro.
Carr JA; Lovering AT
Neuropeptides; 2000 Feb; 34(1):69-75. PubMed ID: 10688972
[TBL] [Abstract][Full Text] [Related]
53. Endogenous opiates and behavior: 2012.
Bodnar RJ
Peptides; 2013 Dec; 50():55-95. PubMed ID: 24126281
[TBL] [Abstract][Full Text] [Related]
54. Somatostatin receptors in the nucleus accumbens modulate dopamine-dependent but not acetylcholine-dependent turning behaviour of rats.
Ikeda H; Kotani A; Koshikawa N; Cools AR
Neuroscience; 2009 Mar; 159(3):974-81. PubMed ID: 19356681
[TBL] [Abstract][Full Text] [Related]
55. Powerful inhibitory action of mu opioid receptors (MOR) on cholinergic interneuron excitability in the dorsal striatum.
Ponterio G; Tassone A; Sciamanna G; Riahi E; Vanni V; Bonsi P; Pisani A
Neuropharmacology; 2013 Dec; 75():78-85. PubMed ID: 23891638
[TBL] [Abstract][Full Text] [Related]
56. A vehicle injection into the right core of the nucleus accumbens both reverses the region-specificity and alters the type of contralateral turning elicited by unilateral stimulation of dopamine D2/D3 and D1 receptors in the left core of the nucleus accumbens.
Ikeda H; Kotani A; Koshikawa N; Cools AR
Eur J Pharmacol; 2007 Dec; 577(1-3):64-70. PubMed ID: 17884038
[TBL] [Abstract][Full Text] [Related]
57. Endomorphin-2 and endomorphin-1 promote the extracellular amount of accumbal dopamine via nonopioid and mu-opioid receptors, respectively.
Okutsu H; Watanabe S; Takahashi I; Aono Y; Saigusa T; Koshikawa N; Cools AR
Neuropsychopharmacology; 2006 Feb; 31(2):375-83. PubMed ID: 16034447
[TBL] [Abstract][Full Text] [Related]
58. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
Noble F; Cox BM
Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
[TBL] [Abstract][Full Text] [Related]
59. Intra-VTA injections of the mu-opioid antagonist CTOP enhance locomotor activity.
Badiani A; Leone P; Stewart J
Brain Res; 1995 Aug; 690(1):112-6. PubMed ID: 7496796
[TBL] [Abstract][Full Text] [Related]
60. Dopamine depletion reorganizes projections from the nucleus accumbens and ventral pallidum that mediate opioid-induced motor activity.
Churchill L; Klitenick MA; Kalivas PW
J Neurosci; 1998 Oct; 18(19):8074-85. PubMed ID: 9742174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
